Tolerant B lymphocytes acquire resistance to fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded

被引:54
作者
Foote, LC
Marshak-Rothstein, A
Rothstein, TL
机构
[1] Boston Univ, Med Ctr, Dept Microbiol, Boston, MA 02118 USA
[2] Boston Univ, Med Ctr, Dept Pathol, Boston, MA 02118 USA
[3] Boston Univ, Med Ctr, Dept Med, Boston, MA 02118 USA
[4] Boston Univ, Med Ctr, Evans Mem Dept Clin Res, Boston, MA 02118 USA
关键词
D O I
10.1084/jem.187.6.847
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility to Fas-mediated apoptosis in nontolerant B cells is regulated in a receptor-specific fashion. To explore the regulation of Fas killing in tolerant, autoreactive B cells, mice doubly transgenic for hen egg lysozyme (HEL)-specific B cell receptors and soluble HEL were examined. Engagement of CD40 led to enhanced Fas expression and acquisition of sensitivity to Fas-mediated apoptosis in tolerant B cells, similar to that observed in nontolerant, receptor transgenic B cells. Engagement of surface immunoglobulin by specific (HEL) antigen failed to induce Fas resistance in tolerant B cells, in contrast to its effect on nontolerant B cells; however, cross-linking of biotinylated HEL with streptavidin induced similar levels of Fas resistance in tolerant and nontolerant B cells, which approximated the degree of Fas resistance produced by anti-Ig. Unlike surface Ig (sig) engagement, physiological engagement of IL-4 receptors produced similar levels of Fas resistance in tolerant and nontolerant B cells. Thus, tolerant B cells differ from nontolerant B cells in the diminished capacity of surface immunoglobulin engagement to produce Fas resistance; however, tolerant B cells can be induced to become resistant to Fas-mediated apoptosis by IL-4 or by higher order cross-linking of sIg receptors.
引用
收藏
页码:847 / 853
页数:7
相关论文
共 35 条
  • [1] Enhanced and accelerated lymphoproliferation in Fas-null mice
    Adachi, M
    Suematsu, S
    Suda, T
    Watanabe, D
    Fukuyama, H
    Ogasawara, J
    Tanaka, T
    Yoshida, N
    Nagata, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) : 2131 - 2136
  • [2] HOMOLOGY OF THE NH2-TERMINAL AMINO-ACID SEQUENCES OF THE HEAVY AND LIGHT-CHAINS OF HUMAN MONOCLONAL LUPUS AUTOANTIBODIES CONTAINING THE DOMINANT 16/6 IDIOTYPE
    ATKINSON, PM
    LAMPMAN, GW
    FURIE, BC
    NAPARSTEK, Y
    SCHWARTZ, RS
    STOLLAR, BD
    FURIE, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1985, 75 (04) : 1138 - 1143
  • [3] BRUNSWICK M, 1988, J IMMUNOL, V140, P3364
  • [4] CARROLL P, 1985, J IMMUNOL, V135, P1086
  • [5] CHEN SZ, 1990, BIOTECHNIQUES, V8, P32
  • [6] IMMUNOGLOBULIN SIGNAL-TRANSDUCTION GUIDES THE SPECIFICITY OF B-CELL T-CELL-INTERACTIONS AND IS BLOCKED IN TOLERANT SELF-REACTIVE B-CELLS
    COOKE, MP
    HEATH, AW
    SHOKAT, KM
    ZENG, YJ
    FINKELMAN, FD
    LINSLEY, PS
    HOWARD, M
    GOODNOW, CC
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) : 425 - 438
  • [7] DIPIRO JT, 1995, ARCH SURG-CHICAGO, V130, P1159
  • [8] POLYSPECIFICITY OF HUMAN MONOCLONAL-ANTIBODIES REACTIVE WITH MYCOBACTERIUM-LEPRAE, MITOCHONDRIA, SSDNA, CYTOSKELETAL PROTEINS, AND THE ACETYLCHOLINE-RECEPTOR
    DUGGAN, DB
    MACKWORTHYOUNG, C
    KARILEFVERT, A
    ANDRESCHWARTZ, J
    MUDD, D
    MCADAM, KPWJ
    SCHWARTZ, RS
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1988, 49 (03): : 327 - 340
  • [9] ERIS JM, 1994, P NATL ACAD SCI USA, V92, P99
  • [10] Foote LC, 1996, J IMMUNOL, V157, P2749